253 related articles for article (PubMed ID: 24790149)
1. Cross-dressing by donor dendritic cells after allogeneic bone marrow transplantation contributes to formation of the immunological synapse and maximizes responses to indirectly presented antigen.
Markey KA; Koyama M; Gartlan KH; Leveque L; Kuns RD; Lineburg KE; Teal BE; MacDonald KP; Hill GR
J Immunol; 2014 Jun; 192(11):5426-33. PubMed ID: 24790149
[TBL] [Abstract][Full Text] [Related]
2. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
3. Cross-dressing: an alternative mechanism for antigen presentation.
Campana S; De Pasquale C; Carrega P; Ferlazzo G; Bonaccorsi I
Immunol Lett; 2015 Dec; 168(2):349-54. PubMed ID: 26551033
[TBL] [Abstract][Full Text] [Related]
4. Cross-dressed dendritic cells sustain effector T cell responses in islet and kidney allografts.
Hughes AD; Zhao D; Dai H; Abou-Daya KI; Tieu R; Rammal R; Williams AL; Landsittel DP; Shlomchik WD; Morelli AE; Oberbarnscheidt MH; Lakkis FG
J Clin Invest; 2020 Jan; 130(1):287-294. PubMed ID: 31763998
[TBL] [Abstract][Full Text] [Related]
5. Copresentation of intact and processed MHC alloantigen by recipient dendritic cells enables delivery of linked help to alloreactive CD8 T cells by indirect-pathway CD4 T cells.
Sivaganesh S; Harper SJ; Conlon TM; Callaghan CJ; Saeb-Parsy K; Negus MC; Motallebzadeh R; Bolton EM; Bradley JA; Pettigrew GJ
J Immunol; 2013 Jun; 190(11):5829-38. PubMed ID: 23630361
[TBL] [Abstract][Full Text] [Related]
6. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
8. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
9. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
10. Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease.
Koyama M; Kuns RD; Olver SD; Raffelt NC; Wilson YA; Don AL; Lineburg KE; Cheong M; Robb RJ; Markey KA; Varelias A; Malissen B; Hämmerling GJ; Clouston AD; Engwerda CR; Bhat P; MacDonald KP; Hill GR
Nat Med; 2011 Nov; 18(1):135-42. PubMed ID: 22127134
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
Coulombe M; Yang H; Wolf LA; Gill RG
J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
[TBL] [Abstract][Full Text] [Related]
12. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases.
Smyth LA; Herrera OB; Golshayan D; Lombardi G; Lechler RI
Transplantation; 2006 Jul; 82(1 Suppl):S15-8. PubMed ID: 16829787
[TBL] [Abstract][Full Text] [Related]
13. Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation.
Brown K; Sacks SH; Wong W
FASEB J; 2008 Nov; 22(11):3776-84. PubMed ID: 18632850
[TBL] [Abstract][Full Text] [Related]
14. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.
Benichou G; Fedoseyeva E; Lehmann PV; Olson CA; Geysen HM; McMillan M; Sercarz EE
J Immunol; 1994 Aug; 153(3):938-45. PubMed ID: 7517977
[TBL] [Abstract][Full Text] [Related]
15. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.
van der Merwe M; Abdelsamed HA; Seth A; Ong T; Vogel P; Pillai AB
J Immunol; 2013 Dec; 191(11):5764-76. PubMed ID: 24190658
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage.
Nouri-Shirazi M; Guinet E
Transplantation; 2002 Oct; 74(7):1035-44. PubMed ID: 12394851
[TBL] [Abstract][Full Text] [Related]
17. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
[TBL] [Abstract][Full Text] [Related]
18. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
19. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes.
Théry C; Duban L; Segura E; Véron P; Lantz O; Amigorena S
Nat Immunol; 2002 Dec; 3(12):1156-62. PubMed ID: 12426563
[TBL] [Abstract][Full Text] [Related]
20. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
Smyth LA; Ratnasothy K; Moreau A; Alcock S; Sagoo P; Meader L; Tanriver Y; Buckland M; Lechler R; Lombardi G
J Immunol; 2013 May; 190(9):4848-60. PubMed ID: 23536635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
